Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review.
[Phenotypes of Charcot-Marie-Tooth Syndrome and Differential Diagnosis Focused in Inflammatory Neuropathies].
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Volumetric Examination of MS Plaques and Correlation with EDSS Ratings.
Current and Future Therapies for Multiple Sclerosis.
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience.
Infodemiology and infoveillance of multiple sclerosis in Italy.
Emerging injectable therapies for multiple sclerosis.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Nurse-led clinics for patients with chronic diseases in hospital and transmural care organizations.
Elderly-onset neuromyelitis optica spectrum disorders.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment.
Clinical outcome measures in multiple sclerosis.
The immunoproteasome: a novel drug target for autoimmune diseases.
Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran.
Oligodendroglial defects during quakingviable cerebellar development.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
[Anti-neurofascin antibody in combined central and peripheral demyelination].

Pages